Balance Therapeutics




Harnessing neuroscience to improve quality of life

Balance Therapeutics is a clinical-stage pharmaceutical company developing therapies to improve the lives of patients with debilitating neurological conditions. We focus on areas of high unmet medical need where neurobiological pathways provide a strong rationale for our pharmacological approach. Our experienced drug development team is committed to advancing products to deliver life-improving medicines that serve patients and their families. Our principal areas of focus are sleep disorders and cognitive deficits.


Now enrolling people with Idiopathic Hypersomnia into our IH202 clinical research program


Balance Therapeutics has raised three rounds of private financing

Investors include Mohr Davidow Ventures, Oakmont Corporation, Orbimed Advisors, Rock Springs Capital, and Pappas Ventures. The company has also received significant R&D support from the U.S. National Institutes of Health.

Contact us


Balance Therapeutics, Inc.
533 Airport Blvd, Suite 400
Burlingame, CA 94010

(650) 741-9100